Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michal Tendera

Showing results (11-20 of 131) with videos related to

Pageof 14
Sort By:
Drugs|March 6, 2007
Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trialWitold Ruzyllo, Michal Tendera, Ian Ford, et al.
Journal of Cardiovascular Computed Tomography|June 20, 2015
Intravenous ivabradine for control of heart rate during coronary CT angiography: A randomized, double-blind, placebo-controlled trialFilippo Cademartiri, Jerome Garot, Michal Tendera, et al.
Pacing and Clinical Electrophysiology : PACE|March 11, 2009
A user-friendly method of cardiac venous system visualization in 64-slice computed tomographyRafal Mlynarski, Maciej Sosnowski, Agnieszka Wlodyka, et al.
Lancet (London, England)|September 2, 2008
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trialKim Fox, Ian Ford, P Gabriel Steg, et al.
American Heart Journal|October 31, 2006
Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the I(f) inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction (BEAUTIFUL) studyKim Fox, Roberto Ferrari, Michal Tendera, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|January 15, 2005
Heart rate variability fraction--a new reportable measure of 24-hour R-R interval variationMaciej Sosnowski, Elaine Clark, Shahid Latif, et al.
European Heart Journal|October 11, 2005
Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable anginaJean-Claude Tardif, Ian Ford, Michal Tendera, et al.
The International Journal of Cardiovascular Imaging|May 6, 2009
Optimal image reconstruction intervals for noninvasive visualization of the cardiac venous system with a 64-slice computed tomographyRafal Mlynarski, Maciej Sosnowski, Agnieszka Wlodyka, et al.
Scandinavian Cardiovascular Journal : SCJ|July 31, 2009
The presence of endocardial leads may limit applicability of coronary CT angiographyMaciej Sosnowski, Rafal Mlynarski, Agnieszka Wlodyka, et al.
European Heart Journal|September 2, 2009
Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trialKim Fox, Ian Ford, Ph Gabriel Steg, et al.
Pageof 14

Showing results (11-20 of 131) with videos related to

Sort By:
Pageof 14
Drugs|March 6, 2007
Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trialWitold Ruzyllo, Michal Tendera, Ian Ford, et al.
Journal of Cardiovascular Computed Tomography|June 20, 2015
Intravenous ivabradine for control of heart rate during coronary CT angiography: A randomized, double-blind, placebo-controlled trialFilippo Cademartiri, Jerome Garot, Michal Tendera, et al.
Pacing and Clinical Electrophysiology : PACE|March 11, 2009
A user-friendly method of cardiac venous system visualization in 64-slice computed tomographyRafal Mlynarski, Maciej Sosnowski, Agnieszka Wlodyka, et al.
Lancet (London, England)|September 2, 2008
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trialKim Fox, Ian Ford, P Gabriel Steg, et al.
American Heart Journal|October 31, 2006
Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the I(f) inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction (BEAUTIFUL) studyKim Fox, Roberto Ferrari, Michal Tendera, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|January 15, 2005
Heart rate variability fraction--a new reportable measure of 24-hour R-R interval variationMaciej Sosnowski, Elaine Clark, Shahid Latif, et al.
European Heart Journal|October 11, 2005
Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable anginaJean-Claude Tardif, Ian Ford, Michal Tendera, et al.
The International Journal of Cardiovascular Imaging|May 6, 2009
Optimal image reconstruction intervals for noninvasive visualization of the cardiac venous system with a 64-slice computed tomographyRafal Mlynarski, Maciej Sosnowski, Agnieszka Wlodyka, et al.
Scandinavian Cardiovascular Journal : SCJ|July 31, 2009
The presence of endocardial leads may limit applicability of coronary CT angiographyMaciej Sosnowski, Rafal Mlynarski, Agnieszka Wlodyka, et al.
European Heart Journal|September 2, 2009
Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trialKim Fox, Ian Ford, Ph Gabriel Steg, et al.
Pageof 14